{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T16:52:40Z","timestamp":1794847960660,"version":"4.9.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06297-6","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T14:41:02Z","timestamp":1741272062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Unveiling ac4C modification pattern: a prospective target for improving the response to immunotherapeutic strategies in melanoma"],"prefix":"10.1186","volume":"23","author":[{"given":"Jianlan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengpeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binlin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3254-6406","authenticated-orcid":false,"given":"Jian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"issue":"28","key":"6297_CR1","doi-asserted-by":"publisher","first-page":"eadm8206","DOI":"10.1126\/sciadv.adm8206","volume":"10","author":"NR Love","year":"2024","unstructured":"Love NR, Williams C, Killingbeck EE, Merleev A, Saffari Doost M, Yu L, McPherson JD, Mori H, Borowsky AD, Maverakis E, et al. Melanoma progression and prognostic models drawn from single-cell, Spatial maps of benign and malignant tumors. Sci Adv. 2024;10(28):eadm8206.","journal-title":"Sci Adv"},{"issue":"10400","key":"6297_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","volume":"402","author":"GV Long","year":"2023","unstructured":"Long GV, Swetter SM, Menzies AM, Gershenwald JE, Scolyer RA. Cutaneous melanoma. Lancet. 2023;402(10400):485\u2013502.","journal-title":"Lancet"},{"key":"6297_CR3","doi-asserted-by":"publisher","first-page":"31432","DOI":"10.1038\/srep31432","volume":"6","author":"J Lv","year":"2016","unstructured":"Lv J, Dai B, Kong Y, Shen X, Kong J. Acral melanoma in Chinese: A clinicopathological and prognostic study of 142 cases. Sci Rep. 2016;6:31432.","journal-title":"Sci Rep"},{"key":"6297_CR4","doi-asserted-by":"crossref","unstructured":"Lim SY, Rizos H. Single-cell RNA sequencing in melanoma: what have we learned so far? EBioMedicine. 2024;100:104969.","DOI":"10.1016\/j.ebiom.2024.104969"},{"issue":"19","key":"6297_CR5","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1158\/1078-0432.CCR-21-0809","volume":"27","author":"PA Ascierto","year":"2021","unstructured":"Ascierto PA, Dr\u00e9no B, Larkin J, Ribas A, Liszkay G, Maio M, Mandal\u00e0 M, Demidov L, Stroyakovskiy D, Thomas L, et al. 5-Year outcomes with Cobimetinib plus Vemurafenib in BRAFV600 Mutation-Positive advanced melanoma: extended Follow-up of the cobrim study. Clin Cancer Res. 2021;27(19):5225\u201335.","journal-title":"Clin Cancer Res"},{"issue":"10304","key":"6297_CR6","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","volume":"398","author":"MS Carlino","year":"2021","unstructured":"Carlino MS, Larkin J, Long GV. Immune checkpoint inhibitors in melanoma. Lancet. 2021;398(10304):1002\u201314.","journal-title":"Lancet"},{"issue":"2","key":"6297_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1200\/JCO.21.02229","volume":"40","author":"JD Wolchok","year":"2022","unstructured":"Wolchok JD, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P, Lao CD, Cowey CL, Schadendorf D, Wagstaff J, Dummer R, et al. Long-Term outcomes with nivolumab plus ipilimumab or nivolumab alone versus ipilimumab in patients with advanced melanoma. J Clin Oncol. 2022;40(2):127\u201337.","journal-title":"J Clin Oncol"},{"issue":"8","key":"6297_CR8","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1200\/JCO.2015.62.9345","volume":"34","author":"GV Long","year":"2016","unstructured":"Long GV, Weber JS, Infante JR, Kim KB, Daud A, Gonzalez R, Sosman JA, Hamid O, Schuchter L, Cebon J, et al. Overall survival and durable responses in patients with BRAF V600-Mutant metastatic melanoma receiving Dabrafenib combined with Trametinib. J Clin Oncol. 2016;34(8):871\u20138.","journal-title":"J Clin Oncol"},{"issue":"7","key":"6297_CR9","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.cell.2018.10.030","volume":"175","author":"D Arango","year":"2018","unstructured":"Arango D, Sturgill D, Alhusaini N, Dillman AA, Sweet TJ, Hanson G, Hosogane M, Sinclair WR, Nanan KK, Mandler MD, et al. Acetylation of cytidine in mRNA promotes translation efficiency. Cell. 2018;175(7):1872\u2013e18861824.","journal-title":"Cell"},{"issue":"7","key":"6297_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41568-021-00357-x","volume":"21","author":"S Zhao","year":"2021","unstructured":"Zhao S, Allis CD, Wang GG. The Language of chromatin modification in human cancers. Nat Rev Cancer. 2021;21(7):413\u201330.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"6297_CR11","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/s11427-023-2496-5","volume":"67","author":"L Tao","year":"2024","unstructured":"Tao L, Lu Y, Chen Z, Ge L, He J, Peng J, Wang H. RNA ac(4)C modification in cancer biology: from regulatory mechanisms to clinical applications. Sci China Life Sci. 2024;67(4):832\u20135.","journal-title":"Sci China Life Sci"},{"issue":"2","key":"6297_CR12","doi-asserted-by":"publisher","first-page":"eadh9871","DOI":"10.1126\/sciadv.adh9871","volume":"10","author":"Z Hu","year":"2024","unstructured":"Hu Z, Lu Y, Cao J, Lin L, Chen X, Zhou Z, Pu J, Chen G, Ma X, Deng Q, et al. N-acetyltransferase NAT10 controls cell fates via connecting mRNA cytidine acetylation to chromatin signaling. Sci Adv. 2024;10(2):eadh9871.","journal-title":"Sci Adv"},{"issue":"1","key":"6297_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41368-023-00276-7","volume":"16","author":"X Wang","year":"2024","unstructured":"Wang X, Ling R, Peng Y, Qiu W, Chen D. RNPS1 stabilizes NAT10 protein to facilitate translation in cancer via tRNA ac(4)C modification. Int J Oral Sci. 2024;16(1):6.","journal-title":"Int J Oral Sci"},{"issue":"3","key":"6297_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/cac2.12523","volume":"44","author":"D Miao","year":"2024","unstructured":"Miao D, Shi J, Lv Q, Tan D, Zhao C, Xiong Z, Zhang X. NAT10-mediated ac(4)C-modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear-cell renal cell carcinoma by attenuating YWHAE-driven cytoplasmic retention of YAP1. Cancer Commun (Lond). 2024;44(3):361\u201383.","journal-title":"Cancer Commun (Lond)"},{"key":"6297_CR15","doi-asserted-by":"crossref","unstructured":"Liu H, Xu L, Yue S, Su H, Chen X, Liu Q, Li H, Liang H, Chen X, He J et al. Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation. Cancer Commun (Lond). 2024;44(9):1018\u201341.","DOI":"10.1002\/cac2.12595"},{"key":"6297_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.omtn.2020.01.037","volume":"20","author":"G Jin","year":"2020","unstructured":"Jin G, Xu M, Zou M, Duan S. The processing, gene regulation, biological functions, and clinical relevance of N4-Acetylcytidine on RNA: A systematic review. Mol Ther Nucleic Acids. 2020;20:13\u201324.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"10","key":"6297_CR17","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1158\/0008-5472.CAN-22-2233","volume":"83","author":"R Xie","year":"2023","unstructured":"Xie R, Cheng L, Huang M, Huang L, Chen Z, Zhang Q, Li H, Lu J, Wang H, Zhou Q, et al. NAT10 drives cisplatin chemoresistance by enhancing ac4C-Associated DNA repair in bladder Cancer. Cancer Res. 2023;83(10):1666\u201383.","journal-title":"Cancer Res"},{"issue":"1","key":"6297_CR18","doi-asserted-by":"publisher","first-page":"7250","DOI":"10.1038\/s41467-022-34877-3","volume":"13","author":"C Zhang","year":"2022","unstructured":"Zhang C, Shen H, Yang T, Li T, Liu X, Wang J, Liao Z, Wei J, Lu J, Liu H, et al. A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma. Nat Commun. 2022;13(1):7250.","journal-title":"Nat Commun"},{"issue":"48","key":"6297_CR19","doi-asserted-by":"publisher","first-page":"20429","DOI":"10.1073\/pnas.0905139106","volume":"106","author":"D Bogunovic","year":"2009","unstructured":"Bogunovic D, O\u2019Neill DW, Belitskaya-Levy I, Vacic V, Yu YL, Adams S, Darvishian F, Berman R, Shapiro R, Pavlick AC, et al. Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. Proc Natl Acad Sci U S A. 2009;106(48):20429\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"6297_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/jid.2012.283","volume":"133","author":"GJ Mann","year":"2013","unstructured":"Mann GJ, Pupo GM, Campain AE, Carter CD, Schramm SJ, Pianova S, Gerega SK, De Silva C, Lai K, Wilmott JS, et al. BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma. J Invest Dermatol. 2013;133(2):509\u201317.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"6297_CR21","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/ijc.29047","volume":"136","author":"K Jayawardana","year":"2015","unstructured":"Jayawardana K, Schramm SJ, Haydu L, Thompson JF, Scolyer RA, Mann GJ, M\u00fcller S, Yang JY. Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, MicroRNA, and protein information. Int J Cancer. 2015;136(4):863\u201374.","journal-title":"Int J Cancer"},{"issue":"3","key":"6297_CR22","doi-asserted-by":"publisher","first-page":"lqaa078","DOI":"10.1093\/nargab\/lqaa078","volume":"2","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Parmigiani G, Johnson WE. ComBat-seq: batch effect adjustment for RNA-seq count data. NAR Genom Bioinform. 2020;2(3):lqaa078.","journal-title":"NAR Genom Bioinform"},{"key":"6297_CR23","doi-asserted-by":"crossref","unstructured":"Fan C, Chen F, Chen Y, Huang L, Wang M, Liu Y, Wang Y, Guo H, Zheng N, Liu Y et al. IrGSEA: the integration of single-cell rank-based gene set enrichment analysis. Brief Bioinform. 2024;25(4).","DOI":"10.1093\/bib\/bbae243"},{"key":"6297_CR24","doi-asserted-by":"crossref","unstructured":"Jin S, Plikus MV, Nie Q. CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics. Nat Protoc. 2025;20(1):180\u2013219.","DOI":"10.1038\/s41596-024-01045-4"},{"issue":"4","key":"6297_CR25","doi-asserted-by":"publisher","first-page":"e13409","DOI":"10.1111\/cpr.13409","volume":"56","author":"N Zhang","year":"2023","unstructured":"Zhang N, Zhang H, Liu Z, Dai Z, Wu W, Zhou R, Li S, Wang Z, Liang X, Wen J, et al. An artificial intelligence network-guided signature for predicting outcome and immunotherapy response in lung adenocarcinoma patients based on 26 machine learning algorithms. Cell Prolif. 2023;56(4):e13409.","journal-title":"Cell Prolif"},{"issue":"1","key":"6297_CR26","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Liu L, Weng S, Guo C, Dang Q, Xu H, Wang L, Lu T, Zhang Y, Sun Z, et al. Machine learning-based integration develops an immune-derived LncRNA signature for improving outcomes in colorectal cancer. Nat Commun. 2022;13(1):816.","journal-title":"Nat Commun"},{"issue":"4","key":"6297_CR27","doi-asserted-by":"publisher","first-page":"e15070","DOI":"10.1111\/exd.15070","volume":"33","author":"J Xie","year":"2024","unstructured":"Xie J, Wu D, Zhang P, Zhao S, Qi M. Deciphering cutaneous melanoma prognosis through LDL metabolism: Single-cell transcriptomics analysis via 101 machine learning algorithms. Exp Dermatol. 2024;33(4):e15070.","journal-title":"Exp Dermatol"},{"issue":"11","key":"6297_CR28","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747\u201356.","journal-title":"Genome Res"},{"key":"6297_CR29","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, Trevi\u00f1o V, Shen H, Laird PW, Levine DA, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"7693","key":"6297_CR30","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, Kadel EE III, Koeppen H, Astarita JL, Cubas R, et al. TGF\u03b2 attenuates tumour response to PD-L1 Blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138.","journal-title":"Nature"},{"issue":"1","key":"6297_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","volume":"165","author":"W Hugo","year":"2016","unstructured":"Hugo W, Zaretsky JM, Sun L, Song C, Moreno BH, Hu-Lieskovan S, Berent-Maoz B, Pang J, Chmielowski B, Cherry G, et al. Genomic and transcriptomic features of response to Anti-PD-1 therapy in metastatic melanoma. Cell. 2016;165(1):35\u201344.","journal-title":"Cell"},{"issue":"1","key":"6297_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s40537-023-00844-y","volume":"10","author":"Z Liu","year":"2023","unstructured":"Liu Z, Liu L, Weng S, Xu H, Xing Z, Ren Y, Ge X, Wang L, Guo C, Li L, et al. BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors. J Big Data. 2023;10(1):165.","journal-title":"J Big Data"},{"issue":"12","key":"6297_CR33","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1074\/mcp.M500279-MCP200","volume":"4","author":"M Uhl\u00e9n","year":"2005","unstructured":"Uhl\u00e9n M, Bj\u00f6rling E, Agaton C, Szigyarto CA, Amini B, Andersen E, Andersson AC, Angelidou P, Asplund A, Asplund C, et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteom. 2005;4(12):1920\u201332.","journal-title":"Mol Cell Proteom"},{"issue":"9","key":"6297_CR34","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/cac2.12595","volume":"44","author":"H Liu","year":"2024","unstructured":"Liu H, Xu L, Yue S, Su H, Chen X, Liu Q, Li H, Liang H, Chen X, He J, et al. Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation. Cancer Commun (Lond). 2024;44(9):1018\u201341.","journal-title":"Cancer Commun (Lond)"},{"key":"6297_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.omtn.2023.03.023","volume":"32","author":"L Xie","year":"2023","unstructured":"Xie L, Zhong X, Cao W, Liu J, Zu X, Chen L. Mechanisms of NAT10 as ac4C writer in diseases. Mol Ther Nucleic Acids. 2023;32:359\u201368.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"15","key":"6297_CR36","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1016\/j.molcel.2022.05.016","volume":"82","author":"D Arango","year":"2022","unstructured":"Arango D, Sturgill D, Yang R, Kanai T, Bauer P, Roy J, Wang Z, Hosogane M, Schiffers S, Oberdoerffer S. Direct epitranscriptomic regulation of mammalian translation initiation through N4-acetylcytidine. Mol Cell. 2022;82(15):2797\u2013e28142711.","journal-title":"Mol Cell"},{"issue":"1","key":"6297_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41392-021-00489-4","volume":"6","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Jing Y, Wang Y, Tang J, Zhu X, Jin WL, Wang Y, Yuan W, Li X, Li X. NAT10 promotes gastric cancer metastasis via N4-acetylated COL5A1. Signal Transduct Target Ther. 2021;6(1):173.","journal-title":"Signal Transduct Target Ther"},{"issue":"25","key":"6297_CR38","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1056\/NEJMc1713444","volume":"377","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan M, Hopkins A, Jaffee EM. Tumor mutational burden and response rate to PD-1 Inhibition. N Engl J Med. 2017;377(25):2500\u20131.","journal-title":"N Engl J Med"},{"issue":"6230","key":"6297_CR39","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","volume":"348","author":"NA Rizvi","year":"2015","unstructured":"Rizvi NA, Hellmann MD, Snyder A, Kvistborg P, Makarov V, Havel JJ, Lee W, Yuan J, Wong P, Ho TS, et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 Blockade in non-small cell lung cancer. Science. 2015;348(6230):124\u20138.","journal-title":"Science"},{"issue":"8","key":"6297_CR40","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: Understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 2020;17(8):807\u201321.","journal-title":"Cell Mol Immunol"},{"key":"6297_CR41","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cca.2020.10.030","volume":"511","author":"F Jiang","year":"2020","unstructured":"Jiang F, Wu C, Wang M, Wei K, Zhou G, Wang J. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma. Clin Chim Acta. 2020;511:306\u201318.","journal-title":"Clin Chim Acta"},{"key":"6297_CR42","doi-asserted-by":"crossref","unstructured":"Berg JS, Derfler BH, Pennisi CM, Corey DP, Cheney RE. Myosin-X, a novel myosin with pleckstrin homology domains, associates with regions of dynamic actin. J Cell Sci. 2000;113(Pt 19):3439\u201351.","DOI":"10.1242\/jcs.113.19.3439"},{"issue":"6","key":"6297_CR43","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nrm2406","volume":"9","author":"PK Mattila","year":"2008","unstructured":"Mattila PK, Lappalainen P. Filopodia: molecular architecture and cellular functions. Nat Rev Mol Cell Biol. 2008;9(6):446\u201354.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"6297_CR44","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/bjc.2014.298","volume":"111","author":"R Cao","year":"2014","unstructured":"Cao R, Chen J, Zhang X, Zhai Y, Qing X, Xing W, Zhang L, Malik YS, Yu H, Zhu X. Elevated expression of myosin X in tumours contributes to breast cancer aggressiveness and metastasis. Br J Cancer. 2014;111(3):539\u201350.","journal-title":"Br J Cancer"},{"issue":"7","key":"6297_CR45","doi-asserted-by":"publisher","first-page":"e67552","DOI":"10.1371\/journal.pone.0067552","volume":"8","author":"G Bidkhori","year":"2013","unstructured":"Bidkhori G, Narimani Z, Hosseini Ashtiani S, Moeini A, Nowzari-Dalini A, Masoudi-Nejad A. Reconstruction of an integrated genome-scale co-expression network reveals key modules involved in lung adenocarcinoma. PLoS ONE. 2013;8(7):e67552.","journal-title":"PLoS ONE"},{"issue":"10","key":"6297_CR46","doi-asserted-by":"publisher","first-page":"8244","DOI":"10.18632\/oncotarget.3135","volume":"6","author":"Y Sun","year":"2015","unstructured":"Sun Y, Ai X, Shen S, Lu S. NF-\u03baB-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10. Oncotarget. 2015;6(10):8244\u201354.","journal-title":"Oncotarget"},{"issue":"2","key":"6297_CR47","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3892\/or.2015.4411","volume":"35","author":"CP Chen","year":"2016","unstructured":"Chen CP, Sun ZL, Lu X, Wu WX, Guo WL, Lu JJ, Han C, Huang JQ, Fang Y. MiR-340 suppresses cell migration and invasion by targeting MYO10 in breast cancer. Oncol Rep. 2016;35(2):709\u201316.","journal-title":"Oncol Rep"},{"issue":"10","key":"6297_CR48","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1016\/j.celrep.2015.11.012","volume":"13","author":"KA Makowska","year":"2015","unstructured":"Makowska KA, Hughes RE, White KJ, Wells CM, Peckham M. Specific myosins control actin organization, cell morphology, and migration in prostate Cancer cells. Cell Rep. 2015;13(10):2118\u201325.","journal-title":"Cell Rep"},{"issue":"1","key":"6297_CR49","doi-asserted-by":"publisher","first-page":"10449","DOI":"10.1038\/s41598-018-28717-y","volume":"8","author":"H Tokuo","year":"2018","unstructured":"Tokuo H, Bhawan J, Coluccio LM. Myosin X is required for efficient melanoblast migration and melanoma initiation and metastasis. Sci Rep. 2018;8(1):10449.","journal-title":"Sci Rep"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06297-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06297-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06297-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T15:16:32Z","timestamp":1741274192000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06297-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6297"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06297-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University (30 August 2022\/ No.2022-SR-465). Informed consent has been obtained from all participants involved in the study. All animal procedures adhered to the ethical guidelines of the Animal Experiments Committee at Nanjing Medical University (IACUC-2403031).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent to publish was obtained from the study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"287"}}